Home Health HIMSS21 Middle East: Why patient data from the Middle East is being scrutinised like never before

HIMSS21 Middle East: Why patient data from the Middle East is being scrutinised like never before

by Mikael Harris

The group of leading experts gathered virtually to discuss the importance of harnessing technology to gain health insights from data, and their findings were discussed on Day Two of the HIMSS21 Middle East session around ‘Leveraging Data and Technology to Advance Population Health Management’. 

The session participants were: Dr Ada Al-Qunaibet, Director of Public Health Research and Health Statistics, Public Health Authority Saudi Arabia; Dr Charles Alessi, Chief Clinical Officer, HIMSS, UK; Dr LaMar Hasbrouck, Senior Advisor for Population Health and Care Management, Council of Cooperative Health Insurance, Saudi Arabia; and Dr Faisal Al-Refaei, Chief Operating Officer, Dasman Diabetes Institute, Kuwait. The moderator was Dr Nasser Aljehani, Model of Care Lead, Second Health Cluster, Saudi Arabia.

‘The start of an explosion in population health management’
“There’s a focus now that I haven’t seen in years past…with Vision 2030, e-medicine and precision medicine, big data has come into focus and I think, from a perspective of science, it is definitely monumental, and very vital for what we need to infer, what we need to conclude, when it comes to proving hypotheses or disproving hypotheses,” said Al-Qunaibet from Public Health Authority Saudi Arabia.

Alessi believes population health management is about to change: “I think we really are at the start of an explosion in initiatives in population health management, really brought along by the pandemic that, of course, exacerbated a whole host of non-communicable disease as well, where life-long interventions are really at the heart of what we should be doing and clearly identifying these at a population level, before then going into it on a personal level.”

“We want to improve the population health for our 11 million beneficiaries over the course of five years by focusing on five conditions that we’ve deemed, based on our data, to be high burden and high cost, and these conditions are hypertension, diabetes, coronary heart disease, smoking-related [disease] and obesity,” commented Hasbrouck.

According to Hasbrouk, the Population Health 5×5 program will leverage technology to identify care for patients with these long-term conditions. He said data from these special populations of interest will be poured into a registry where clinical data, laboratory data and cost data can be measured. Patients will then be offered customised care, based on the data.     

The costs of ignoring chronic disease
Al-Refaei believes it was a mistake to ignore chronic diseases during the pandemic: “It is very clear from research that has come out from multiple countries, that focusing on the pandemic and ignoring illnesses such as diabetes has actually cost us already, financially and healthcare outcome-based, much more than it cost us to put all our resources into the pandemic.”

“These are not diseases we can change overnight and so trying to have that slow steady input of data, and systems being able to absorb that data, is key…With these diseases, the problem is not like a pandemic or viruses; you can’t give a vaccine to treat obesity and you can’t give a vaccine to treat cardiovascular disease,” commented Al-Qunaibet.

Register now to listen to the session ‘on demand’ at HIMSS21 Middle East.

Source : Healthcare IT News

Related Articles

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

NEWS7.ASIA :HIMSS21 Middle East: Why patient data from the Middle East is being scrutinised like never before
https://climatiseurs-et-ventilateurs.com   https://paris-restos.fr   https://facebookstore.org   https://fringues.biz   https://www.leparadissurterre.fr  
SAC de Rangement pour BÉBÉ LANDOU HOMEASY Sac Organisateur Bandoulière de Poussette Attachable pour Maman bébé Stroller… *  20 mètres -Bordure De Jardin Flexible, avec 20″ Super Fort (Ancres 15 cm) – Bordure De Pelouse, Bordure De Gazon, Bordure en Plastique, Palissade pour Jardin (2×10 mètres, Noir) *  Skechers Go Flex-Stride, Baskets Basses Femme, 37 EU *  * Sporadic multiple renal angiomyolipoma with lymph node involvement: a case report and literature review – DocWire News *  Malignant Mesothelioma Drugs Market Report, History and Forecast 2021-2027| AstraZeneca … *  BQ Witbox 2 – imprimante 3D *  Amscan – PJMASQUES GLUGLU-Gekko – Deguisement – Mixte Enfant – Vert – 3-4 ans, 9902956 *  GROOVE TUBE (Groove Tube) Simple Orange (Three-Dimensional Maze) (Japan Import) *  * How Can It Be *  AI-based Prognostic Tests In Breast Cancer: Why This is a Game Changer – Entrepreneur *  https://www.notre-dame-de-paris.net   https://www.intelli.news/   https://www.casques-audio.com/   https://jeux4video.com   https://www.come2europe.eu   https://www.les-livres.fr/   https://casques-audio.com   https://www.le-paradis-des-bebes.com/   https://www.chaussures.co.com   https://www.sports-chaussures.fr   https://paris-restos.com   https://www.fourniturescolairepascher.com   https://pushkarcity.com   https://sports-chaussures.fr   HIMSS21 Middle East: Why patient data from the Middle East is being scrutinised like never before : news7

news7.asia HIMSS21 Middle East: Why patient data from the Middle East is being scrutinised like never before